Compare SDGR & CMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SDGR | CMP |
|---|---|---|
| Founded | 1990 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Metals and Minerals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2020 | 2003 |
| Metric | SDGR | CMP |
|---|---|---|
| Price | $19.84 | $25.30 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 4 |
| Target Price | $21.00 | ★ $21.50 |
| AVG Volume (30 Days) | ★ 1.1M | 487.3K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.14 | N/A |
| EPS | N/A | ★ 0.59 |
| Revenue | ★ $255,869,000.00 | N/A |
| Revenue This Year | $0.76 | N/A |
| Revenue Next Year | $4.60 | $1.29 |
| P/E Ratio | ★ N/A | $42.79 |
| Revenue Growth | ★ 23.29 | N/A |
| 52 Week Low | $10.95 | $16.40 |
| 52 Week High | $23.02 | $34.50 |
| Indicator | SDGR | CMP |
|---|---|---|
| Relative Strength Index (RSI) | 63.80 | 44.07 |
| Support Level | $17.23 | $24.82 |
| Resistance Level | N/A | $25.80 |
| Average True Range (ATR) | 1.01 | 1.04 |
| MACD | 0.08 | 0.13 |
| Stochastic Oscillator | 80.79 | 39.89 |
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.
Compass Minerals currently produces two primary products: salt and specialty potash fertilizer. The company's main assets include rock salt mines in Ontario, Louisiana, and the United Kingdom. The fertilizer is produced from a brine operation at the Great Salt Lake in Utah that produces sulfate of potash and magnesium chloride. Compass' salt products are used for deicing and also by industrial and consumer end markets. The firm's sulfate of potash is used by growers of high-value crops that are sensitive to standard potash.